Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice
Maxwell P. Lee, Jason D. Ravenel, Ren-Ju Hu, Lawrence R. Lustig, Gordon Tomaselli, Ronald D. Berger, Sheri A. Brandenburg, Tracy J. Litzi, Tracie E. Bunton, Charles Limb, Howard Francis, Melissa Gorelikow, Hua Gu, Kay Washington, Pedram Argani, James R. Goldenring, Robert J. Coffey, Andrew P. Feinberg
Maxwell P. Lee, Jason D. Ravenel, Ren-Ju Hu, Lawrence R. Lustig, Gordon Tomaselli, Ronald D. Berger, Sheri A. Brandenburg, Tracy J. Litzi, Tracie E. Bunton, Charles Limb, Howard Francis, Melissa Gorelikow, Hua Gu, Kay Washington, Pedram Argani, James R. Goldenring, Robert J. Coffey, Andrew P. Feinberg
View: Text | PDF
Article

Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice

  • Text
  • PDF
Abstract

The KvLQT1 gene encodes a voltage-gated potassium channel. Mutations in KvLQT1 underlie the dominantly transmitted Ward-Romano long QT syndrome, which causes cardiac arrhythmia, and the recessively transmitted Jervell and Lange-Nielsen syndrome, which causes both cardiac arrhythmia and congenital deafness. KvLQT1 is also disrupted by balanced germline chromosomal rearrangements in patients with Beckwith-Wiedemann syndrome (BWS), which causes prenatal overgrowth and cancer. Because of the diverse human disorders and organ systems affected by this gene, we developed an animal model by inactivating the murine Kvlqt1. No electrocardiographic abnormalities were observed. However, homozygous mice exhibited complete deafness, as well as circular movement and repetitive falling, suggesting imbalance. Histochemical study revealed severe anatomic disruption of the cochlear and vestibular end organs, suggesting that Kvlqt1 is essential for normal development of the inner ear. Surprisingly, homozygous mice also displayed threefold enlargement by weight of the stomach resulting from mucous neck cell hyperplasia. Finally, there were no features of BWS, suggesting that Kvlqt1 is not responsible for BWS.

Authors

Maxwell P. Lee, Jason D. Ravenel, Ren-Ju Hu, Lawrence R. Lustig, Gordon Tomaselli, Ronald D. Berger, Sheri A. Brandenburg, Tracy J. Litzi, Tracie E. Bunton, Charles Limb, Howard Francis, Melissa Gorelikow, Hua Gu, Kay Washington, Pedram Argani, James R. Goldenring, Robert J. Coffey, Andrew P. Feinberg

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Gastric pathology in Kvlqt1 knockout mice. Compared with paraffin sectio...
Gastric pathology in Kvlqt1 knockout mice. Compared with paraffin sections of wild-type fundic mucosa (a), Kvlqt1 knockout mouse fundic mucosa (b) showed increased epithelial cell proliferation as measured by Ki67 indirect immunoperoxidase. In both cases, however, the proliferative zone was properly placed in the isthmic region of the glands. This zone was expanded in the knockout mouse, and the overall mucosal thickness was increased owing to increased numbers of epithelial cells in the deeper compartments. PAS staining in gastric fundus of wild-type mice (c) and homozygous mutant mice (d) was largely confined to the apical portions of normal foveolar epithelial cells. In mutant mice, a broad zone of less intensely staining cells was present in the midportion of the mucosa, and the PAS staining of surface mucous cells was reduced (d). Hematoxylin and eosin staining of cells in the neck region of the mutant mice (e) showed dilated glands with many mucinous cells and vacuolated parietal cells. Immunostaining for H/K-ATPase (f) demonstrated staining in the cytoplasm of these parietal cells without staining of the intracellular vacuoles. Immunostaining of mucous neck cells for spasmolytic polypeptide in wild-type mice (g) showed staining of a small number of cells in the isthmic region. Prominent spasmolytic polypeptide staining was observed in knockout mouse hyperplastic mucous cells (h) along the entire length of the gland. Immunostaining for intrinsic factor in wild-type (i) and knockout (j) mice showed decreased numbers of chief cells in mutant mice. Bar, 40 μm (a, b, i, and j), 20 μm (c and d), 10 μm (e and f), and 60 μm (g and h).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts